The securities of Innate Immunotherapeutics Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Monday, 20 March 2017 or when the announcement is released to the market.
For further information please download PDF attached:
Download this document
